Related Experiment Video
Updated: May 22, 2026
12:52
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Basic concepts in glioma immunology.
1Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA. parney.ian@mayo.edu
Advances in Experimental Medicine and Biology
|May 29, 2012
Summary
Glioblastomas, aggressive brain tumors, have poor outcomes. This review explores brain tumor immunology and immunosuppression to improve immunotherapy strategies for glioma patients.
Area of Science:
- Neuro-immunology
- Oncology
- Immunotherapy
Background:
- Glioblastomas are aggressive primary brain tumors with poor prognoses.
- Immunotherapy offers a promising avenue for experimental treatment.
- Understanding brain tumor immunobiology is crucial for effective glioblastoma immunotherapy.
Purpose of the Study:
- To review basic immunology and neuro-immunology relevant to brain tumors.
- To discuss antigenic factors in glioma immunotherapy.
- To outline mechanisms of glioma-mediated immunosuppression.
Main Methods:
- Review of basic immunology and neuro-immunology.
- Discussion of glioma-associated and glioma-specific antigens.
- Evaluation of molecular and cellular aspects of immunosuppression in glioma.
Main Results:
- Glioblastomas are characterized by complex immunosuppressive mechanisms.
- Multiple cell types contribute to local and systemic immunosuppression.
- Antigenic targets for immunotherapy are being identified.
Conclusions:
- A comprehensive understanding of brain tumor immunology is essential for advancing glioblastoma immunotherapy.
- Targeting immunosuppressive pathways may enhance treatment efficacy.
- Further research into glioma antigens and immune cell interactions is warranted.
